DISC-1459 FDA decision

The FDA issued a complete response letter for DISC-1459 (Bitopertin) on 13 Feb 2026.

FDA decision
13 Feb 2026

Drug identity checked against registry records

Also recorded as Bitopertin; RO4917838

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2026-02-13DayDISC-1459Disc Medicine, Inc · IRONFDA complete response letterComplete response letterNot specifiedOpen original source
Read source excerpt

{"application_number": ["NDA 220707"], "letter_date": "02/13/2026", "letter_type": "COMPLETE RESPONSE", "company_name": "Disc Medicine, Inc.", "file_name": "CRL_NDA220707_20260213.pdf"}

First seen: 26 Sep 2026 · Evidence last checked: 26 Sep 2026